Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at MRD

por Waldschmidt, Johannes M., Anand, Praveen, Knoechel, Birgit, Lohr, Jens G.
Publicado en Semin Hematol (2018)

Tracking myeloma tumor DNA in peripheral blood

por Waldschmidt, Johannes M., Vijaykumar, Tushara, Knoechel, Birgit, Lohr, Jens G.
Publicado en Best Pract Res Clin Haematol (2020)

Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years

por Engelhardt, Monika, Ihorst, Gabriele, Landgren, Ola, Pantic, Milena, Reinhardt, Heike, Waldschmidt, Johannes, May, Annette M., Schumacher, Martin, Kleber, Martina, Wäsch, Ralph
Publicado en Haematologica (2015)

Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib

por Eismann, Julia, Heng, Yujing J., Waldschmidt, Johannes M., Vlachos, Ioannis S., Gray, Kathryn P., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A., Murphy, Charles J., Nabavi, Sheida, Wulf, Gerburg M.
Publicado en J Cancer Res Clin Oncol (2019)

Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly,...

por Waldschmidt, Johannes M., Keller, Alexander, Ihorst, Gabriele, Grishina, Olga, Müller, Stefan, Wider, Dagmar, Frey, Anna V., King, Kristina, Simon, Roman, May, Annette, Tassone, Pierfrancesco, Duyster, Justus, Jung, Manfred, Raje, Noopur, Wäsch, Ralph, Engelhardt, Monika
Publicado en Haematologica (2018)